Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Progress and prospects of xeroderma pigmentosum therapy.

Sarasin A.

Adv Exp Med Biol. 2008;637:144-51. Review. No abstract available.

PMID:
19181120
2.

[Interferon as a stimulator of DNA repair in patients with xeroderma pigmentosum].

Zasukhina GD, L'vova GN, Chekova VV, Prokhorov AIu, Mordovtsev VN.

Genetika. 1993 Nov;29(11):1821-5. Russian.

PMID:
7508409
3.

Xeroderma pigmentosum: from symptoms and genetics to gene-based skin therapy.

Magnaldo T, Sarasin A.

Cells Tissues Organs. 2004;177(3):189-98. Review.

PMID:
15388993
4.

Xeroderma pigmentosum.

Norgauer J, Idzko M, Panther E, Hellstern O, Herouy Y.

Eur J Dermatol. 2003 Jan-Feb;13(1):4-9. Review.

5.

Xeroderma pigmentosum and related disorders: examining the linkage between defective DNA repair and cancer.

Kraemer KH, Levy DD, Parris CN, Gozukara EM, Moriwaki S, Adelberg S, Seidman MM.

J Invest Dermatol. 1994 Nov;103(5 Suppl):96S-101S. Review.

PMID:
7963692
6.

Xeroderma pigmentosum: from genetics to hopes and realities of cutaneous gene therapy.

Magnaldo T.

Expert Opin Biol Ther. 2004 Feb;4(2):169-79. Review.

PMID:
14998776
7.

On the search for skin gene therapy strategies of xeroderma pigmentosum disease.

Menck CF, Armelini MG, Lima-Bessa KM.

Curr Gene Ther. 2007 Jun;7(3):163-74. Review.

PMID:
17584035
8.

DNA damage and gene therapy of xeroderma pigmentosum, a human DNA repair-deficient disease.

Dupuy A, Sarasin A.

Mutat Res. 2015 Jun;776:2-8. doi: 10.1016/j.mrfmmm.2014.08.007. Epub 2014 Sep 6. Review.

PMID:
26255934
9.

Gene targeting and in vivo gene transfer.

Tanaka K.

Cell Transplant. 1994;3 Suppl 1:S55-6. Review. No abstract available.

PMID:
8162311
10.

Functional retroviral vector for gene therapy of xeroderma pigmentosum group D patients.

Carreau M, Quilliet X, Eveno E, Salvetti A, Danos O, Heard JM, Mezzina M, Sarasin A.

Hum Gene Ther. 1995 Oct;6(10):1307-15.

PMID:
8590735
13.

Preferential repair of nuclear matrix associated DNA in xeroderma pigmentosum complementation group C.

Mullenders LH, van Kesteren AC, Bussmann CJ, van Zeeland AA, Natarajan AT.

Mutat Res. 1984 Oct;141(2):75-82.

PMID:
6493270
14.

Retrovirus-mediated gene transfer corrects DNA repair defect of xeroderma pigmentosum cells of complementation groups A, B and C.

Zeng L, Quilliet X, Chevallier-Lagente O, Eveno E, Sarasin A, Mezzina M.

Gene Ther. 1997 Oct;4(10):1077-84.

15.

[Case report on xeroderma pigmentosum].

Meffert H.

Padiatr Grenzgeb. 1974;13(2-3):177-82. German. No abstract available.

PMID:
4408760
16.

[Mechanisms of impairment of DNA repair in human cells. Interferons stimulated DNA repair in xeroderma pigmentosum cells].

Sinel'shchikova TA, Chekova VV, Zasukhina GD.

Genetika. 1989 Sep;25(9):1658-63. Russian.

PMID:
2513259
17.

Genetic correction of stem cells in the treatment of inherited diseases and focus on xeroderma pigmentosum.

Rouanet S, Warrick E, Gache Y, Scarzello S, Avril MF, Bernerd F, Magnaldo T.

Int J Mol Sci. 2013 Oct 9;14(10):20019-36. doi: 10.3390/ijms141020019. Review.

18.

Management of xeroderma pigmentosum.

Osguthorpe JD, Lang P.

Arch Otolaryngol Head Neck Surg. 1987 Mar;113(3):292-4.

PMID:
3814373
19.

Unique DNA repair properties of a xeroderma pigmentosum revertant.

Cleaver JE, Cort├ęs F, Lutze LH, Morgan WF, Player AN, Mitchell DL.

Mol Cell Biol. 1987 Sep;7(9):3353-7.

20.

The nucleotide excision repair of DNA in human cells and its association with xeroderma pigmentosum.

Gratchev A.

Adv Exp Med Biol. 2008;637:113-9. Review. No abstract available.

PMID:
19181116

Supplemental Content

Support Center